Zalcitabine

This classification denotes a pyrimidine antagonist with the molecular formula C9H13N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6L3XT8CB3I, chemically known as dideoxycytidine but generally known as zalcitabine, which bears US NIH Compound Identifier 24066. European Medicines Agency schedules Zalcitabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00130MIG. The term ZALCITABINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). World Health Organization schedules zalcitabine in its Anatomical Therapeutic Chemical (ATC) Classification. ZALCITABINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zalcitabine under HS 29349990 and SITC 51579. As of Q4 2014, ZALCITABINE remains the US FDA Preferred Term for this commodity. Zalcitabine bears US NLM identifiers UMLS ID C0012132 and NCI Concept Code C430. SMILES: O1C(N2CCC(NC2=O)N)CCC1CO.